This guideline replaces Guideline on Modified Release Oral and Transdermal Dosage Forms Section II 9 (Pharmacokinetic and Clinical Evaluation (EMA/CPMP/EWP/280/96 Corr*)).

 

Download document Draft guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms (EMA/CPMP/EWP/280/96 Corr1)
Reference number EMA/CHMP/EWP/280/96 Rev.1
Status draft: consultation open
First published 15/03/2013
Last updated 15/03/2013
Consultation start date 15/03/2013
Consultation end date 15/09/2013
Email address for submissions PKWPsecretariat@ema.europa.eu

 

Posted on the EMA website on 15 March 2013